Masatoshi Shimo

Fukuoka, 8128582, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Early prediction of ICANS using CRS characteristics in B-cell lymphoma patients receiving CAR-T therapy.

Early prediction of ICANS using CRS characteristics in B-cell lymphoma patients receiving CAR-T therapy.

Journal: International journal of hematology

Published: February 25, 2026

p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors.

p62/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 29, 2026

Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma.

Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma.

Journal: Cancer science

Published: August 21, 2025

Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Safety and effectiveness of lisocabtagene maraleucel following PD-1 blockade in relapsed or refractory PMBCL.

Journal: International journal of hematology

Published: August 01, 2025

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

The effective and safe administration of Epcoritamab in relapsed CD19-CD5+ DLBCL following CAR-T therapy.

Journal: Blood cell therapy

Published: December 23, 2024

Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy.

Cerebrospinal fluid proteomics exerts predictive potential for immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR-T cell therapy.

Journal: Leukemia

Published: September 01, 2024

A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.

A case of successful CAR-T cell therapy for early isolated CNS recurrence of DLBCL with persistent CAR-T cells.

Journal: Blood cell therapy

Published: October 27, 2023

Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.

Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.

Journal: International journal of clinical oncology

Published: December 21, 2022

A Case of a Malignant Lymphoma Patient Persistently Infected with SARS-CoV-2 for More than 6 Months.

A Case of a Malignant Lymphoma Patient Persistently Infected with SARS-CoV-2 for More than 6 Months.

Journal: Medicina (Kaunas, Lithuania)

Published: December 09, 2022

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force.

Journal: Nature communications

Published: December 14, 2021

DOCK2 is involved in the host genetics and biology of severe COVID-19.

DOCK2 is involved in the host genetics and biology of severe COVID-19.

Journal: Nature

Published: October 26, 2021

Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.

Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.

Journal: Internal medicine (Tokyo, Japan)

Published: July 28, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026